Enhancement of myeloperoxidase activity in wbcs in oral cancer patients treated with granulocyte macrophage colony stimulating factor (GM-CSF) - A pilot study

N. Ananth; B. Balaji Ganesh; D. M. Vasudevan; Vivian D. Souza; Ashalatha V. Rao; Dinesh Nambiar

doi:10.1007/BF02867875

Enhancement of myeloperoxidase activity in wbcs in oral cancer patients treated with granulocyte macrophage colony stimulating factor (GM-CSF) - A pilot study

N. Ananth, B. Balaji Ganesh, D. M. Vasudevan, Vivian D. Souza, Ashalatha V. Rao, Dinesh Nambiar

Research output: Contribution to journal › Article › peer-review

Abstract

In a pilot study with five oral cancer patients undergoing radiotherapy (RT) three were given Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as a protective agent to reduce the mucosal inflammation during radiotherapy. The myeloperoxidase (MPO) enzyme activity in WBC was quantitated. The three patients snowed a significant increase in the MPO activity when compared with two untreated controls indicating the efficacy of GM-CSF as a protective agent. It is suggested that further detailed studies with larger number of patients would be useful.

Original language	English
Pages (from-to)	126-128
Number of pages	3
Journal	Indian Journal of Clinical Biochemistry
Volume	13
Issue number	2
DOIs	https://doi.org/10.1007/BF02867875
Publication status	Published - 01-01-1998
Externally published	Yes

All Science Journal Classification (ASJC) codes

Clinical Biochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/BF02867875

Cite this

@article{a45b7a4ae1794edc9c58f97b28857226,

title = "Enhancement of myeloperoxidase activity in wbcs in oral cancer patients treated with granulocyte macrophage colony stimulating factor (GM-CSF) - A pilot study",

abstract = "In a pilot study with five oral cancer patients undergoing radiotherapy (RT) three were given Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as a protective agent to reduce the mucosal inflammation during radiotherapy. The myeloperoxidase (MPO) enzyme activity in WBC was quantitated. The three patients snowed a significant increase in the MPO activity when compared with two untreated controls indicating the efficacy of GM-CSF as a protective agent. It is suggested that further detailed studies with larger number of patients would be useful.",

author = "N. Ananth and \{Balaji Ganesh\}, B. and Vasudevan, \{D. M.\} and Souza, \{Vivian D.\} and Rao, \{Ashalatha V.\} and Dinesh Nambiar",

year = "1998",

month = jan,

day = "1",

doi = "10.1007/BF02867875",

language = "English",

volume = "13",

pages = "126--128",

journal = "Indian Journal of Clinical Biochemistry",

issn = "0970-1915",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Enhancement of myeloperoxidase activity in wbcs in oral cancer patients treated with granulocyte macrophage colony stimulating factor (GM-CSF) - A pilot study

AU - Ananth, N.

AU - Balaji Ganesh, B.

AU - Vasudevan, D. M.

AU - Souza, Vivian D.

AU - Rao, Ashalatha V.

AU - Nambiar, Dinesh

PY - 1998/1/1

Y1 - 1998/1/1

N2 - In a pilot study with five oral cancer patients undergoing radiotherapy (RT) three were given Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as a protective agent to reduce the mucosal inflammation during radiotherapy. The myeloperoxidase (MPO) enzyme activity in WBC was quantitated. The three patients snowed a significant increase in the MPO activity when compared with two untreated controls indicating the efficacy of GM-CSF as a protective agent. It is suggested that further detailed studies with larger number of patients would be useful.

AB - In a pilot study with five oral cancer patients undergoing radiotherapy (RT) three were given Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as a protective agent to reduce the mucosal inflammation during radiotherapy. The myeloperoxidase (MPO) enzyme activity in WBC was quantitated. The three patients snowed a significant increase in the MPO activity when compared with two untreated controls indicating the efficacy of GM-CSF as a protective agent. It is suggested that further detailed studies with larger number of patients would be useful.

UR - https://www.scopus.com/pages/publications/77949937455

UR - https://www.scopus.com/inward/citedby.url?scp=77949937455&partnerID=8YFLogxK

U2 - 10.1007/BF02867875

DO - 10.1007/BF02867875

M3 - Article

AN - SCOPUS:77949937455

SN - 0970-1915

VL - 13

SP - 126

EP - 128

JO - Indian Journal of Clinical Biochemistry

JF - Indian Journal of Clinical Biochemistry

IS - 2

ER -

Enhancement of myeloperoxidase activity in wbcs in oral cancer patients treated with granulocyte macrophage colony stimulating factor (GM-CSF) - A pilot study

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this